We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Share Name | Share Symbol | Market | Type | Share ISIN | Share Description |
---|---|---|---|---|---|
Optibiotix Health Plc | LSE:OPTI | London | Ordinary Share | GB00BP0RTP38 | ORD 2P |
Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
---|---|---|---|---|---|---|---|---|---|---|
0.00 | 0.00% | 18.25 | 17.50 | 19.00 | 18.25 | 18.25 | 18.25 | 44,934 | 01:00:00 |
Industry Sector | Turnover | Profit | EPS - Basic | PE Ratio | Market Cap |
---|---|---|---|---|---|
Noncomml Resh Organizations | 457k | 2.59M | 0.0284 | 6.43 | 16.64M |
Date | Subject | Author | Discuss |
---|---|---|---|
14/7/2017 10:24 | Quite sad the lengths some losers would go to, to try and get in at a low price. Sitting infront of the screen all day making up usernames etc LOL. Although, it also goes to show that deep down they believe in the company too. That's why they stick around like a bad smell, knowing the price will sky rocket soon, but wanting to instil a lack of confidence so they can take advantage. 56 negative posts in a day says it all :) | loungeact | |
14/7/2017 10:01 | Loving the surge in price today.It's gonna break 60p soon. | talkingtrade | |
14/7/2017 09:01 | I'm afraid the early signs are for yet another drip day :( Our time will come though | judijudi | |
14/7/2017 08:16 | hear, hear shazbo, John | 2350220 | |
14/7/2017 07:54 | Better still... let's see if we can rise a penny for every post you make ; ) | siennadelekat21 | |
14/7/2017 07:49 | Goood moooorning all!!!Let's see if we can hold 60p today... | talkingtrade | |
14/7/2017 07:46 | You desperately need the share price to bounce hard from here my little filtered trolls. See post 1536 from yesterday:- "Investors will need significant news on revenue generation from Opti in the very near future or the chart won't hold here, and once the share price falls below the 60p support then where it will stop is anybody's guess? It is looking like a 4d pharma scenario. Not even a dead cat bounce today. We're nearly 8 months into their financial year and there's not a whisper about revenues, cash remaining, cash burn etc. That's not a good sign." It's no surprise that this appears to be the main thread now. I knew it would be!!! | michaelmouse | |
14/7/2017 02:13 | Talking Trades, nicely avoided. Everybody missed the one where you ignored the point about bod failing on promises and ahead of commercial production of 3 products. You should use michaelmouses tactic, filter elrico because he made you look a fool. You were just reeling off post after post in a desperate attempt to hide elricos answers. The same tactic michaelmouse used. | pglancy | |
14/7/2017 01:53 | Elrico munched them, end of. | incanus | |
13/7/2017 23:43 | TT maybe you should RE read your posts when you are off your meds.. I suspect a certain mouse read your nonsense with pride today and that by itself should tell you something. | 1bokke | |
13/7/2017 22:52 | I know Zebbo; Donald Trump induces a laugh in me every now and then, too. He does say some funny things, doesn't he? What a ticket! | owenmo | |
13/7/2017 22:47 | Well..I was bored today..Working from home with man flu... | talkingtrade | |
13/7/2017 22:35 | TT what a card. I've had a real good laugh at the posts tonight. | zebbo | |
13/7/2017 22:26 | The earliest example of the filibuster in the Commons, as far as I know, emanated from an Irishman - one Joseph Biggar - in 1874. Talkintrades to-day posted 56 times, no less. It is my considered opinion - allowing that I do not believe he is soft in the head - that this presents in a disingenuous, dishonest-even framework. Let no-one tell me it is to serve open debate. It is clearly obsessive and hopefully self-serving. For shame. Can't we somehow delimit conspiracies of this kind? 5 comments per day, maybe - but 56! Riddle me that. Unless, of course, indeed he is MM by another name, in which case all bets are off. | owenmo | |
13/7/2017 22:17 | Elrico...You tried...Lol... | talkingtrade | |
13/7/2017 22:14 | TT - sorry pal, I cannot be held accountable for your lack of understanding. I suggest reading and digesting post1569. You seem obsessed with yogurts. This was early demonstration of a particular strain which needed further work. Future RNSs stated there were 4000 strains that needed testing. The yogurts were just vehicles for the science. NIZO helped identify the strains then further tests compiled by Reading Uni.If you don't understand this, then truly, OPTI is not for you.Each post become more desperate. You are blinded and I must accept you are hell bent of disinformation, deceit or you simply don't understand OPTI. I prefer the latter but fear the former. ? | elrico | |
13/7/2017 21:16 | Elrico..please just answer the questions and stop trying to complicate the issue.You have not answered one question directly.Your answers are vague..why..because the information provided by the company is vague. | talkingtrade | |
13/7/2017 21:14 | First one...nothing materialised after 3 years...Second statement. Let's see where we are in three years.It seems they have difficulty from concept to on the shelves.. | talkingtrade | |
13/7/2017 21:11 | Stephen O'Hara, CEO of OptiBiotix, commented: "We are really pleased with the results of this study which opens up opportunities for the development of a range of natural sweet prebiotic fibres which can be used to replace sugar in food and beverages. These may be classified as dietary fibres, which from an industry and consumer perspective, creates the prospect of substituting high calorie sugars with sweet healthy fibres. With growing public and political concerns over traditional sugars and artificial sweeteners OptiBiotix is leading research in an area of growing industry interest | talkingtrade | |
13/7/2017 21:10 | Compare and contrast:Stephen O'Hara, CEO of OptiBiotix, commented: "These studies are encouraging and show early potential for incorporating OptiBiotix's proprietary weight management formulation into dairy products such as yoghurts. This supports our aim of extending the range of food types which can incorporate our weight management formulation, increasing the number of products and partnering opportunities. This will help OptiBiotix build a valuable and sustainable business and support governments around the world in the fight against obesity." | talkingtrade | |
13/7/2017 21:08 | Above is very similar to the Wight loss formulation that opened doors into.the obesity market across multiple products.That was three years ago.It never happened.We had a few IPs protected but it was never developed. | talkingtrade | |
13/7/2017 21:05 | Ok...What happened to the yoghurts??? | talkingtrade | |
13/7/2017 21:04 | TT - First off, a link to help bring down your blood pressure. It must be dangerously high right now. and now....another clue for you. Read and digest, the clues are there. Put that 20 years experience to use instead of reverting to every bears type....attack the bull with childish baiting posts. It's beneath you and embarrassing for you. Who do you think helped identify the strains? The independent test have only just been published. These back up earlier taste tests by NIZO. Now OPTI will need to file new patents and IP before producing anything. Or would you prefer they just ran with it and lost IP? 11 July 2017 OptiBiotix Health plc ("OptiBiotix" or the Company") SweetBiotix(R) development: Results of human taste study OptiBiotix Health plc (AIM: OPTI), a life sciences business developing compounds to tackle obesity, high cholesterol and diabetes, announces successful human taste studies in its SweetBiotix(R) product development programme. The programme has been designed to develop sweet natural healthy fibres, called SweetBiotix(R) , which are not digested in the human gut, and hence calorie free. The study was carried out by The Flavour and Sensory Science Centre at the University of Reading who tested six customised oligosaccharides developed from high intensity sweeteners which were compared to sucrose. The study used a trained expert panel of ten experienced panellists and showed:- -- The customised oligosaccharides showed sweetness of between 140X and 223X that of sucrose at equivalent concentrations -- Customised oligosaccharides derived from Stevia showed a large reduction in bitterness whilst not affecting its sweetness The results of this independent study provide proof of product concept for a natural, low calorie, SweetBiotix(R). This is an innovative concept which has the potential to address public health concerns over the impact of sugar on obesity, with the prospect of replacing 'unhealthy' sugars in existing products with low calorie, healthy non-digestible fibres, trademarked as SweetBiotix(R). Given the global sweetener market, currently dominated by sugar, is forecast to reach $112bn by 2022 (Mordor Intelligence, 2017), the Company are filing additional patents to add a further layer of protection to the existing intellectual property portfolio to protect their inventions and fully exploit the commercial potential. Stephen O'Hara, CEO of OptiBiotix, commented: "We are really pleased with the results of this study which opens up opportunities for the development of a range of natural sweet prebiotic fibres which can be used to replace sugar in food and beverages. These may be classified as dietary fibres, which from an industry and consumer perspective, creates the prospect of substituting high calorie sugars with sweet healthy fibres. With growing public and political concerns over traditional sugars and artificial sweeteners OptiBiotix is leading research in an area of growing industry interest." | elrico | |
13/7/2017 20:52 | TT is within 1 strike of being "one over the eight"; 8 posts on the trot; I'm now re-asseiing just who it is that's obsessively soft in the head. Should there not be a stop loss on posts? | owenmo |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions